StockNews.AI
LFWD
StockNews.AI
172 days

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

1. Lifeward Ltd. will release Q4 and fiscal year-end results on March 7, 2025. 2. CEO and CFO will host a conference call to discuss results. 3. Company focuses on innovative medical technology for rehabilitation and disabilities. 4. Lifeward's product portfolio includes advanced rehabilitation solutions like ReWalk and AlterG. 5. Archived results and call accessible through Lifeward’s website for investors.

Earnings
+1.74%Current Return
VS
+1.56%S&P 500
$1.7202/28 08:04 AM EDTEvent Start
$1.7503/03 08:31 AM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

The upcoming earnings report holds potential for positive performance insight, similar to previous quarterly reports where high innovation expectations led to price increases. Past earnings (e.g., Q3 2024) boosted market interest when innovation was highlighted.

How important is it?

The earnings report is crucial for investor sentiment, directly affecting stock performance and market positioning in competitive medical tech.

Why Short Term?

Positive earnings/releases tend to have immediate effects on stock prices, mirroring historical trends where favorable financial disclosures led to price spikes in the following sessions.

Related Companies

RTTRINSPLIFE
February 28, 2025 08:00 ET  | Source: Lifeward Ltd. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and fiscal year-end financial results before the markets open on Friday, March 7, 2025. Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following: Toll free (U.S.)1-833-316-0561International (U.S)1-412-317-0690Germany0800-6647650Israel1-80-9212373Access CodePlease reference the “Lifeward Earnings Call” The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/9u4xjdep. An archived webcast will also be available on the company's website. About Lifeward Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com. Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.    Lifeward Media Relations:Kathleen O’DonnellVP Marketing & New Business DevelopmentLifeward Ltd.E: media@golifeward.comLifeward Investor Contact:Mike LawlessChief Financial OfficerLifeward Ltd.E: ir@golifeward.com

Related News